SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-015831
Filing Date
2021-08-05
Accepted
2021-08-05 16:01:26
Documents
15
Period of Report
2021-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crdf-20210805.htm   iXBRL 8-K 39505
2 EX-99.1 crdf8521-q22021pr.htm EX-99.1 134261
6 cardiff_logoxrgbxtm.jpg GRAPHIC 176318
7 crdf-20210805_g1.jpg GRAPHIC 176318
  Complete submission text file 0001628280-21-015831.txt   987170

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crdf-20210805.xsd EX-101.SCH 1935
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crdf-20210805_lab.xml EX-101.LAB 23007
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crdf-20210805_pre.xml EX-101.PRE 12131
8 EXTRACTED XBRL INSTANCE DOCUMENT crdf-20210805_htm.xml XML 10034
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35558 | Film No.: 211148042
SIC: 2836 Biological Products, (No Diagnostic Substances)